In addition to serving as a pediatric neurologist at the Children's Hospital of Georgia, Dr. Elizabeth Sekul works as an associate professor at the Medical College of Georgia's Department of Neurology and the Department of Pediatrics and Child Neurology.
Her research has been published in several academic journals and she continues to be one of the most highly-sought-after physicians in her field of study.
She received her certification from the American Board of Neuropsychology, and she earned her medical degree from the University of Mississippi School of Medicine.
Areas of Expertise (4)
Botulinum toxin injections
Pediatric Neuromuscular Disorders
Millsaps College: Bachelor's Degree, Chemistry
University of Mississippi School of Medicine: Doctorate in medicine
Children's Hospital of Alabama: Internship
Children's Hospital of Alabama, Neurology: Residency
Baylor College of Medicine: Fellowship, Child Neurology
Indium 111 diethylenetriamine pentaacetic acid scintigraphy in the identification and management of intrathecal pump malfunctionPubMed
June Yowtak 1, Kelsie Cato, Hadyn Williams, Pamela Salazar, Samuel Macomson, Elizabeth Sekul, John Vender
Intrathecal drug-delivery systems have become widely used tools in the management of refractory chronic pain and spasticity. Because increasing numbers of patients are using these systems, rehabilitation specialists frequently are the initial care providers who identify clinical signs and symptoms indicating possible complications relating to the implanted system. Identification of a pump malfunction often presents a diagnostic challenge. Distinguishing among progression of disease, new organic problems, and/or drug-device complications is critical. The use of nuclear medicine indium 111 diethylenetriamine pentaacetic acid (DTPA) studies represents a highly effective, straightforward, minimally invasive way to assess implant function and drug distribution.
Needle EMG in certain uncommon clinical contextsWiley Online Library
Gloria Galloway, MD, Chair; Michael Andary, MD, MS; Andrea Boon, MD; Neil Busis, MD; Joseph Campellone Jr., MD; Michael Chang, MD; David Goodenough, MD; Vern Juel, MD; Richard Malamut, MD; Gregory Mulford, MD; Devon Rubin, MD; Kyle Ruffing, MD; Elizabeth Sekul, MD; Zachary Simmons, MD; Benn Smith, MD; and Vincent Tranchitella, MD
It is the position of the AANEM that, based on the literature, there are no contraindications to needle electromyography (EMG) in patients with lymphedema or prosthetic joints. In patients with lymphedema, clinical judgment in each individual circumstance should be used in deciding whether the risk of complication is greater than the value of the information to be obtained from the needle electrode examination. Muscle Nerve, 2005
Lambert-Eaton Myasthenic syndrome in a child with an autoimmune phenotypeNational Library of Medicine
William H Hoffman 1, Sandra W Helman, Elizabeth Sekul, James E Carroll, Roger A Vega
We report on a child with a family history of autoimmune defects, who presented at the age of 3(1/2) years with alopecia and Graves disease. He subsequently developed vitiligo and psoriasis. At 9(1/2) years, he developed an autoimmune form of Lambert-Eaton Myasthenic syndrome (LEMS) with a significant elevation of glutamic acid decarboxylase (GAD) autoantibodies. Shortly thereafter he developed chronic urticaria. HLA associations were present for Graves disease, vitiligo, psoriasis, and IgA deficiency. There was also evidence of autoimmunity involving the pancreatic islet cells and gastric parietal cells.